Hospital website homepage is changing

20 Mar 2018, 1:36 p.m.

Exciting changes are afoot on the Great Ormond Street Hospital (GOSH) website (www.gosh.nhs.uk).

As part of a careful, user-centred research project, we will be making small and frequent improvements to the website in the next couple of months. Huge thanks to all of you, who participated in the surveys, interviews and workshops to get the website to this point.

The first major change is to place a new video/image banner on the homepage. The unresponsive carousel of images has been replaced with a single engaging video, which brings to life the hospital experience. This video/image will be updated regularly to reflect the vital services the hospital provides. It will change dependent on what patients, parents and their families tell us they want to see.

Rest assured all the content links which featured in the carousel previously can be found, either from the top navigation or from the content areas listed on the current homepage.

Keep your eyes peeled for more significant changes and if you have any questions and feedback, please contact web.content@gosh.org

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)

By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer